Dr. Andras Heczey, MD
Scientific Director of Translational Research Cell, Gene and Protein Therapeutics, Seattle Children's Research Institute; Janet and Jim Sinegal Endowed Chair in Pediatric Solid Tumor Research in honor of Korey Rose; Professor of Pediatrics, Ben Towne Center for Childhood Cancer and Blood Disorders Research, University of Washington
Andras Heczey MD is a physician scientist and Professor of Pediatrics in the Division of Pediatric Hematology and Oncology, University of Washington. He is the Scientific Director of Translational Research - Cell, Gene and Protein Therapeutics at the Seattle Children’s Research Institute (SCRI). He is a member of the multidisciplinary Solid Tumor team of Seattle Children’s the Ben Towne Cancer Center of SCRI, and the Immunotherapy Integrated Research Center of the Fred Hutch Cancer Center. He has over 15 years’ experience in developing first-in-human / first-in-child cell and gene therapeutics in the preclinical and clinical setting. His lab has strong emphasis on effective collaborations to ensure rapid preclinical testing, cost effective cGMP process development and timely clinical trial implementation. The main focus of the lab is on novel cell and gene therapies for children and adults with solid tumors using state-of-the-art synthetic immunology and genetic engineering tools to redirect the immune system and eliminate cancer. His work has been focused on developing safe and effective CAR T cell treatments for children with solid tumors with a dedicated focus on pediatric liver tumors including hepatoblastoma.
Dr. Heczey’s Work
Clinical Trial enrolling children with relapsed/refractory hepatoblastoma